ProKidney Corp.
PROK
$3.02
-$0.28-8.49%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -3.91% | 202.63% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.91% | 202.63% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -3.91% | 202.63% | |||
| SG&A Expenses | -2.14% | 20.98% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.06% | -19.42% | |||
| Operating Income | 4.06% | 19.75% | |||
| Income Before Tax | 3.33% | 20.14% | |||
| Income Tax Expenses | 43.49% | -65.28% | |||
| Earnings from Continuing Operations | 2.60% | 21.72% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -3.79% | -22.01% | |||
| Net Income | 1.09% | 21.36% | |||
| EBIT | 4.06% | 19.75% | |||
| EBITDA | 3.88% | 20.42% | |||
| EPS Basic | 2.39% | 21.87% | |||
| Normalized Basic EPS | 0.00% | -3.77% | |||
| EPS Diluted | 2.39% | 21.87% | |||
| Normalized Diluted EPS | 0.00% | -3.77% | |||
| Average Basic Shares Outstanding | 1.36% | 0.60% | |||
| Average Diluted Shares Outstanding | 1.36% | 0.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||